Invests in
Locations:
Min Investment:
$10,000,000.00Max Investment:
$40,000,000.00Target Investment:
$25,000,000.00
Skills
Education
- Uo
Lists including Mike
Work Experience
2021
Partner
2024
Venture Partner
2021 - 2023
2020 - 2024
Board Member, Audit Committee Chair and Member of Compensation Committee
2020 - 2024
2017 - 2021
Operating Partner
2017 - 2021
2018 - 2020
Member of the Board of Directors
2018 - 2020
2016 - 2017
Chief Operating Officer, Santa Rosa
2016 - 2017
2010 - 2016
Chief Financial Officer
2010 - 2016
Cardiovascular device manufacturer focused on treatment of abdominal aortic aneurysms. Successfully completed a $91 million initial public offering in April 2014. Sold to Endologix in February 2016 for approximately $211 Million.
2006 - 2010
Chief Financial Officer
2006 - 2010
Public cardiovascular device manufacturer providing solutions for heart valve disease and atrial fibrillation. Sold to Medtronic in August 2010 for approximately $375 Million.
2005 - 2006
Controller
2005 - 2006
Public cardiac surgery company developing an artificial bypass graft for CABG surgery.
2004 - 2005
Manager, Financial Analysis
2004 - 2005
2001 - 2004
Manager, Assurance and Advisory Services
2001 - 2004